Adipokines, particularly leptin and adiponectin, act on various molecular targets in response to OSA, mediating systemic metabolic changes in response to physiological perturbations and sleep disturbances [13]. The gene discussed is ADIPOQ; the disease is obstructive sleep apnea syndrome.